Showing results (731-740 of 782) with videos related to

Sort By:
Pageof 79
Mutagenesis|April 25, 2002
Assessment of the genotoxic potential of ISIS 2302: a phosphorothioate oligodeoxynucleotideScott P Henry, D K Monteith, J E Matson, et al.
Plastic and Reconstructive Surgery. Global Open|July 28, 2026
Use of Smartphone Activity Data to Monitor and Identify Trends in Recovery After Breast Reduction SurgeryRichard M Kwasnicki, Laurie M Tupper, Joshua Hon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 3, 2012
Outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli O104:H4 among French tourists returning from Turkey, September 2011N Jourdan-da Silva, M Watrin, F X Weill, et al.
Mediators of Inflammation|May 8, 2014
Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent modelsAlexander J Szalai, Mark A McCrory, Dongqi Xing, et al.
Ecotoxicology and Environmental Safety|April 30, 2019
In ovo exposure to brominated flame retardants Part II: Assessment of effects of TBBPA-BDBPE and BTBPE on hatching success, morphometric and physiological endpoints in American kestrelsMargaret L Eng, Natalie K Karouna-Renier, Paula F P Henry, et al.
Early Intervention in Psychiatry|March 1, 2011
Early Psychosis Prevention and Intervention Centre long-term follow-up study of first-episode psychosis: methodology and baseline characteristicsLisa P Henry, Meredith G Harris, G Paul Amminger, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 10, 2024
Quantifying postoperative recovery using wearable activity monitors following abdominal wall surgery: The AbTech trialRichard Mark Kwasnicki, Emmanuel Giannas, Chiara Rizk, et al.
Molecular Therapy. Nucleic Acids|May 11, 2016
Elucidation of the Biotransformation Pathways of a Galnac3-conjugated Antisense Oligonucleotide in Rats and MonkeysColby S Shemesh, Rosie Z Yu, Hans J Gaus, et al.
Nucleic Acid Therapeutics|August 9, 2016
Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in MonkeysRosie Z Yu, Rudy Gunawan, Noah Post, et al.
Nucleic Acid Therapeutics|February 6, 2025
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry RecommendationsPatrik Andersson, Sebastien A Burel, Heather Estrella, et al.
Pageof 79